Glenmark Pharmaceuticals Ltd

As per the Code of Conduct for Prevention of Insider Trading and pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from March 31 2023 to May 21 2023 (both days inclusive) for the purpose of approval of Audited Financial Results for the Quarter and year ended March 31 2023.